Differentiation between the Regulatory paths placed on Mouthwashes in the US and EU
Regulating oral rinses has been and still is a topic of debate and confusion. Oral rinses are products that are mainly used for cleaning, perfuming and changing the appearance of the teeth, which in turn improves the individual’s external appearance. Adding medicinal ingredients to these rinses, it can then be used for the elimination and/or prevention of some oral diseases, an example being gingivitis. The United States Food and Drug Administration placed guidelines which state that mouthwashes with possible therapeutic properties should be registered as drugs rather than cosmetics. Meanwhile, on a different continent, Germany along with the other members of the European Union decided not to categorize mouthwashes as drugs, but rather as cosmetics, using its sole purpose of cleaning and beautifying the teeth as the excuse. The following research will thoroughly differentiate between the diverse regulatory systems forced upon mouthwashes across the two countries—the United States and Germany.
2. Hall M, Hill D, Pave G. Global Pharmaceuticals 2016 industry statistics [Internet]. Hardman and Co.: London; 2017 Mar 02 [Cited 2018 Mar 25]. Available from:
3. European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures (p4 & 7) [Internet]. EFPIA: Belgium; 2017 [Cited 2018 Mar 15]. Available from:
4. Hanan MT and Freeman J. Structural Inertia and Organizational Change. American Sociological Review [Internet]. 1984 Apr [cited 2010 Mar 12]; 49(2):149-64. Available from:
5. US Food & Drug Administration. Drugs @FDA Glossary of Terms. [Internet]. USFDA; 2017 Nov 14 [Cited 2018 Mar 11]. Available from:
6. European Medicines Agency. About the website, Glossary [Internet]. EMEA; 2018 [Cited 2018 Mar 10]. Available from:
7. Federal Institute for Drugs and Medical Devices. Medicinal Products: Evaluating benefit. Minimising risks [Internet].BfArm; 2013 [Cited 2018 Mar 13]. Available from:
8. US Food & Drug Administration. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) [Internet]. USFDA; 2002 Jul 08 [updated 2012 Apr 30; cited 2018 Mar 15]. Available from:
9. US Food & Drug Administration. Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph [Internet]. Federal Register; 2003 May 29 [cited 2018 Mar 16]. Available from:
10. US Food & Drug Administration. The Drug Development Process [Internet]. USFDA; 2018 Jan 04 [cited 2018 Mar 10]. Available from:
11. US Food & Drug Administration. Drug Approval Process. [Internet]. USFDA [cited 2018 Mar 18]. Available from:
12. DR. G. Renner. Legislation of Cosmetics in the EU, Key Features of Regulation 1223/2009/EU (multiple pages) [Internet]. EU:2009 [cited 2018 Mar 19]. Available from:
13. Cosmetics Europe. Understanding the Cosmetics Regulation [Internet]. EU:2018 [cited 2018 Mar 11]. Available from:
14. Cosmetics Europe (2015, March). From Cosmetics Europe guidelines on the product information file (P.I.F.) Requirement [Internet]. EU:2018 [cited 2018 Mar 11]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
Rights of Authors:
The International Journal of Drug Regulatory affairs. recognize the retention of the following:
- Patent and trademark rights and rights to any process or procedure described in the article.
- The right to photocopy or make single electronic copies of the article for their own personal use, including for their own classroom use, or for the personal use of colleagues, provided the copies are not offered for sale and are not distributed in a systematic way outside of their employing institution (e.g. via an e-mail list or public file server). Posting of an article on a secure network (not accessible to the public) within the author’s institution is permitted.
- The right, subsequent to publication, to use the article or any part thereof free of charge in a printed compilation of works of their own, such as collected writings or lecture notes.
Note: All copies, paper, electronic or other use, of the information must include an indication of the IJDRA copyright and a full citation of the journal source.
- If the article was prepared jointly with other author(s), the signing author has informed the co-author(s) of the terms of this copyright transfer and is signing on their behalf as their agent and represents that he or she is authorized to do so, then please confirm by checking the appropriate box following the signature line. The signing author shall bear the responsibility for designating the co-author(s) and must inform the IJDRA of any changes in authorship.
- If copyright is held by the employer, then the employer or an authorized representative of the employer must sign. If the author signs, it is understood that this is with the authorization of the employer and the employer’s acceptance of the terms of the transfer.
The author(s) warrant(s) that the article is the author’s original work and has not been published before. The author(s) warrant(s) that the article contains no libelous or other unlawful statements, and does not infringe on the rights of others. If excerpts from copyrighted works are included, the author(s) has (have) obtained or will obtain written permission from the copyright owners and will credit the source in the article.
Preprints: The author(s) must agree that if a prior version of this work (normally a preprint) has been posted to an electronic public server, they will not update and/or replace the prior version in order to make it identical in content to the final published version.